Today: 17 April 2026
Subscribe
Browse Category

NSE:PAYTM 28 September 2025 - 10 December 2025

Biggest Stock Losers Today in India (10 December 2025): Kaynes Tech, IndiGo, Eris Lifesciences, Paytm Drag NSE & BSE

Biggest Stock Losers Today in India (10 December 2025): Kaynes Tech, IndiGo, Eris Lifesciences, Paytm Drag NSE & BSE

Kaynes Technology fell nearly 8% to ₹3,990 by midday Wednesday, extending a five-day slide after Kotak flagged financial disclosure concerns. The Sensex hovered near 84,645 (‑0.03%) and Nifty 50 was flat, while midcap and smallcap indices slipped about 0.4% and 0.2%. IT and PSU bank stocks dragged, while metals, auto, and realty shares edged higher.
10 December 2025
····
One 97 Communications (Paytm) Share Price on 8 December 2025: RBI Nod, Q2 Results, Broker Targets and 2026 Outlook

One 97 Communications (Paytm) Share Price on 8 December 2025: RBI Nod, Q2 Results, Broker Targets and 2026 Outlook

Shares of One 97 Communications, Paytm’s parent, traded at ₹1,337–1,338 on 8 December 2025, near a 52-week high and up 37% over the past year. Market cap stands at about ₹85,500–86,000 crore. The company posted a ₹123 crore net profit in Q1 FY26, its first from core operations, with operating revenue up 28% year-on-year. Recent gains follow regulatory relief, improved profitability, and broker upgrades.
8 December 2025
·
Paytm (One 97 Communications) Share Price Near 52-Week High: RBI Nod, Q2 FY26 Earnings and Wall Street Upgrades Explained

Paytm (One 97 Communications) Share Price Near 52-Week High: RBI Nod, Q2 FY26 Earnings and Wall Street Upgrades Explained

Paytm parent One 97 Communications traded around ₹1,340–1,360 on 1 December 2025, near its 52-week high and up about 55% in six months. The stock remains roughly 40% below its IPO price of ₹2,150. Trading volumes surged after Paytm Payments Services received final RBI approval to operate as a payment aggregator, lifting previous restrictions. Market cap stands near ₹85,000 crore.
1 December 2025
··

Stock Market Today

  • Eli Lilly Stock Dips Amid Strong GLP-1 Growth Expectations, Valuation Debate
    April 17, 2026, 11:49 AM EDT. Eli Lilly (NYSE: LLY) shares declined recently despite strong GLP-1 drug sales projections. Mounjaro and Zepbound, key products targeting type 2 diabetes and obesity, are expected to drive sales above $40 billion by 2026. Analysts value the stock at $1,189.18, a 24% premium over the current $903.99 price, suggesting undervaluation. However, Eli Lilly trades at a high P/E ratio of 39.2x, compared to 17x for the pharmaceutical sector, indicating investor caution. Concerns remain over insurance coverage and side effects that could impact growth. The debate centers on whether the recent price weakness is a market correction or a buying opportunity for a high-growth biotech with significant risks.

Latest article

XRP Price Today: XRP Climbs to $1.44 as ETF Inflows, Risk-On Mood Lift Ripple-Linked Token

XRP Price Today: XRP Climbs to $1.44 as ETF Inflows, Risk-On Mood Lift Ripple-Linked Token

17 April 2026
XRP climbed to about $1.44 in early New York trading Friday, up 2.5% in 24 hours with turnover over $4 billion, outpacing bitcoin and ether. U.S.-listed spot XRP ETFs saw $17 million in net inflows on April 15, the highest since February. Ripple announced a partnership with Kyobo Life Insurance for Korea’s first tokenised government bond settlement project. XRP remains about 60% below its all-time high.
Gold Price Today Near $4,784 as Weaker Dollar Keeps Bullion on Track for Fourth Weekly Gain

Gold Price Today Near $4,784 as Weaker Dollar Keeps Bullion on Track for Fourth Weekly Gain

17 April 2026
Gold hovered near $4,784 an ounce Friday, set for a fourth weekly gain despite easing 0.1% by 0815 GMT. A 10-day Lebanon-Israel ceasefire and possible U.S.-Iran talks kept investors watching for diplomatic progress. Indian gold imports stalled as banks await new government authorization, leaving over 5 tons stuck at customs. Spot silver rose 0.7% to $78.97, platinum held steady, and palladium slipped 0.1%.
Go toTop